{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:07:49Z","timestamp":1786118869468,"version":"build-2736575974"},"reference-count":58,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1097\/spc.0b013e3282ef5e03","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T04:01:43Z","timestamp":1209873703000},"page":"96-101","source":"Crossref","is-referenced-by-count":21,"title":["Pharmacological management of dyspnoea"],"prefix":"10.1097","volume":"1","author":[{"given":"David C","family":"Currow","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy P","family":"Abernethy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210126","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1164\/ajrccm\/142.5.1009","article-title":"Distinguishable types of dyspnea in patients with shortness of breath","volume":"142","author":"Simon","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"R2-3-20210126","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1378\/chest.118.3.679","article-title":"Descriptors of breathlessness in healthy individuals: distinct and separable constructs","volume":"118","author":"Harver","year":"2000","journal-title":"Chest"},{"key":"R3-3-20210126","first-page":"22","article-title":"Sustained release theophylline reduces dyspnoea in nonreversible obstructive airway disease","volume":"131","author":"Mahler","year":"1985","journal-title":"Am Rev Resp Dis"},{"key":"R4-3-20210126","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/thx.48.3.227","article-title":"Value of theophylline treatment in patients handicapped by chronic obstructive lung disease","volume":"48","author":"McKay","year":"1993","journal-title":"Thorax"},{"key":"R5-3-20210126","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJM198906083202304","article-title":"A randomized, controlled trial of theophylline in patients with severe chronic obstructive pulmonary disease","volume":"320","author":"Murciano","year":"1989","journal-title":"N Engl J Med"},{"key":"R6-3-20210126","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1365-2125.1985.tb02716.x","article-title":"Chlorpromazine \u2014 a specific effect on breathlessness?","volume":"19","author":"O'Neill","year":"1985","journal-title":"Br J Clin Pharmacol"},{"key":"R7-3-20210126","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0007-0971(87)90163-X","article-title":"Effects of chronic administration of codeine and promethazine on breathlessness and exercise tolerance in patients with chronic airflow obstruction","volume":"81","author":"Rice","year":"1987","journal-title":"Br J Dis Chest"},{"key":"R8-3-20210126","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1378\/chest.109.4.975","article-title":"Effect of 30 mg of morphine alone or with promethazine or prochlorperazine on the exercise capacity of patients with COPD","volume":"109","author":"Light","year":"1996","journal-title":"Chest"},{"key":"R9-3-20210126","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/bmj.283.6287.343","article-title":"Drug treatment of breathlessness: contrasting effects of diazepam and promethazine in pink puffers","volume":"283","author":"Woodcock","year":"1981","journal-title":"Br Med J (Clin Res Ed)"},{"key":"R10-3-20210126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1042\/cs0690029","article-title":"Effects of small particle aerosols of local anaesthetic on dyspnoea in patients with respiratory disease","volume":"69","author":"Stark","year":"1985","journal-title":"Clin Sci (Lond)"},{"key":"R11-3-20210126","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1152\/jappl.1987.63.6.2286","article-title":"Aerosol anesthesia increases hypercapnic ventilation and breathlessness in laryngectomized humans","volume":"63","author":"Hamilton","year":"1987","journal-title":"J Appl Physiol"},{"key":"R12-3-20210126","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1164\/ajrccm\/137.5.1094","article-title":"Indomethacin and perception of dyspnea in chronic airflow obstruction","volume":"137","author":"Schiffman","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"R13-3-20210126","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/thorax.57.11.939","article-title":"A systematic review of the use of opioids in the management of dyspnoea","volume":"57","author":"Jennings","year":"2002","journal-title":"Thorax"},{"key":"R14-3-20210126","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1136\/bmj.327.7414.523","article-title":"Randomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoea","volume":"327","author":"Abernethy","year":"2003","journal-title":"BMJ"},{"key":"R16-3-20210126","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S0885-3924(98)00157-2","article-title":"How effective are supplementary doses of opioids for dyspnea in terminally ill cancer patients? A randomized continuous sequential clinical trial","volume":"17","author":"Allard","year":"1999","journal-title":"J Pain Symptom Manage"},{"key":"R17-3-20210126","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S1388-9842(02)00158-7","article-title":"Morphine for the relief of breathlessness in patients with chronic heart failure \u2013 a pilot study","volume":"4","author":"Johnson","year":"2002","journal-title":"Eur J Heart Fail"},{"key":"R18-3-20210126","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1378\/chest.128.5.3322","article-title":"Palliative treatment of dyspnea with epidural methadone in advanced emphysema","volume":"128","author":"Juan","year":"2005","journal-title":"Chest"},{"key":"R19-3-20210126","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1378\/chest.125.2.691","article-title":"Nebulized opioids use in COPD","volume":"125","author":"Foral","year":"2004","journal-title":"Chest"},{"key":"R20-3-20210126","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1345\/aph.1E328","article-title":"Nebulized morphine for relief of dyspnea due to chronic lung disease","volume":"39","author":"Brown","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R22-3-20210126","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0009-9236(97)90079-5","article-title":"Morphine pharmacokinetics after pulmonary administration from a novel aerosol delivery system","volume":"62","author":"Ward","year":"1997","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"R23-3-20210126","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/S0761-8425(04)71583-1","article-title":"Dyspnea and morphine aerosols in the palliative care of lung cancer","volume":"21","author":"Grimbert","year":"2004","journal-title":"Rev Mal Respir"},{"key":"R24-3-20210126","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.jpainsymman.2004.08.016","article-title":"Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study","volume":"29","author":"Bruera","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"R25-3-20210126","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1164\/ajrccm.157.6.9711061","article-title":"The effect of sustained-release morphine on breathlessness and quality of life in severe chronic obstructive pulmonary disease","volume":"157","author":"Poole","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"R26-3-20210126","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1136\/bmj.327.7426.1288-b","article-title":"Morphine for management of refractory dyspnoea: opiates should be used with caution","volume":"327","author":"Berrill","year":"2003","journal-title":"Br Med J"},{"key":"R28-3-20210126","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1023\/A:1008337624200","article-title":"The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial","volume":"10","author":"Mazzocato","year":"1999","journal-title":"Ann Oncol"},{"key":"R29-3-20210126","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1191\/0269216305pm998oa","article-title":"Low dose diamorphine reduces breathlessness without causing a fall in oxygen saturation in elderly patients with end-stage idiopathic pulmonary fibrosis","volume":"19","author":"Allen","year":"2005","journal-title":"Palliat Med"},{"key":"R30-3-20210126","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1046\/j.1365-2125.2000.00141.x","article-title":"The pharmacokinetics of morphine and morphine glucuronide metabolites after subcutaneous bolus injection and subcutaneous infusion of morphine","volume":"49","author":"Stuart-Harris","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"R32-3-20210126","doi-asserted-by":"crossref","first-page":"906","DOI":"10.7326\/0003-4819-119-9-199311010-00007","article-title":"Subcutaneous morphine for dyspnea in cancer patients","volume":"119","author":"Bruera","year":"1993","journal-title":"Ann Intern Med"},{"key":"R33-3-20210126","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0885-3924(01)00381-5","article-title":"A phase I\/II study of nebulized morphine-6-glucuronide in patients with cancer-related breathlessness","volume":"23","author":"Quigley","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"R34-3-20210126","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1056\/NEJM198112313052703","article-title":"Effects of dihydrocodeine, alcohol, and caffeine on breathlessness and exercise tolerance in patients with chronic obstructive lung disease and normal blood gases","volume":"305","author":"Woodcock","year":"1981","journal-title":"N Engl J Med"},{"key":"R35-3-20210126","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1136\/bmj.286.6366.675","article-title":"Dihydrocodeine for breathlessness in \u2018pink puffers\u2019","volume":"286","author":"Johnson","year":"1983","journal-title":"Br Med J"},{"key":"R36-3-20210126","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0735-1097(96)00446-9","article-title":"Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure","volume":"29","author":"Chua","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"R37-3-20210126","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0885-3924(01)00391-8","article-title":"Nebulized fentanyl citrate improves patients' perception of breathing, respiratory rate, and oxygen saturation in dyspnea","volume":"23","author":"Coyne","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"R38-3-20210126","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1183\/09031936.93.04080926","article-title":"Oral diamorphine: lack of effect on dyspnoea and exercise tolerance in the \u2018pink puffer\u2019 syndrome","volume":"4","author":"Eiser","year":"1991","journal-title":"Eur Respir J"},{"key":"R39-3-20210126","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1136\/heart.89.9.1085","article-title":"Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure","volume":"89","author":"Williams","year":"2003","journal-title":"Heart"},{"key":"R40-3-20210126","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.jpainsymman.2005.10.002","article-title":"Oral transmucosal fentanyl citrate in the management of dyspnea crises in cancer patients","volume":"30","author":"Benitez-Rosario","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"R41-3-20210126","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.2146\/ajhp060015","article-title":"Unlabeled uses of nebulized medications","volume":"63","author":"Shirk","year":"2006","journal-title":"Am J Health Syst Pharm"},{"key":"R42-3-20210126","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/j.1875-9114.1989.tb04101.x","article-title":"Effects of alprazolam on respiratory drive, anxiety, and dyspnea in chronic airflow obstruction: a case study","volume":"9","author":"Greene","year":"1989","journal-title":"Pharmacotherapy"},{"key":"R43-3-20210126","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1378\/chest.90.6.832","article-title":"Effect of alprazolam on exercise and dyspnea in patients with chronic obstructive pulmonary disease","volume":"90","author":"Man","year":"1986","journal-title":"Chest"},{"key":"R44-3-20210126","first-page":"9","article-title":"Diazepam in the treatment of dyspnoea in the \u2018Pink Puffer\u2019 syndrome","volume":"49","author":"Mitchell-Heggs","year":"1980","journal-title":"Q J Med"},{"key":"R45-3-20210126","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1742-1241.1983.tb07190.x","article-title":"The response of the breathless patient treated with diazepam","volume":"37","author":"Sen","year":"1983","journal-title":"Br J Clin Pract"},{"key":"R46-3-20210126","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jpainsymman.2005.06.009","article-title":"Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer","volume":"31","author":"Navigante","year":"2006","journal-title":"J Pain Symptom Manage"},{"key":"R47-3-20210126","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0952-0600(89)80016-X","article-title":"Inhaled frusemide is highly effective in preventing ultrasonically nebulised water bronchoconstriction","volume":"1","author":"Robuschi","year":"1989","journal-title":"Pulm Pharmacol"},{"key":"R48-3-20210126","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1164\/ajrccm.161.6.9910009","article-title":"Inhaled furosemide greatly alleviates the sensation of experimentally induced dyspnea","volume":"161","author":"Nishino","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"R49-3-20210126","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJM198910193211602","article-title":"Protective effect of inhaled furosemide on allergen-induced early and late asthmatic reactions","volume":"321","author":"Bianco","year":"1989","journal-title":"N Engl J Med"},{"key":"R50-3-20210126","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0140-6736(88)92540-8","article-title":"Prevention of exercise-induced bronchoconstriction by inhaled frusemide","volume":"2","author":"Bianco","year":"1988","journal-title":"Lancet"},{"key":"R51-3-20210126","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00045391-200207000-00009","article-title":"Furosemide: progress in understanding its diuretic, anti-inflammatory, and bronchodilating mechanism of action, and use in the treatment of respiratory tract diseases","volume":"9","author":"Prandota","year":"2002","journal-title":"Am J Ther"},{"key":"R52-3-20210126","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1006\/pupt.2002.0376","article-title":"Effects of inhaled furosemide on CO(2) ventilatory responsiveness in humans","volume":"15","author":"Minowa","year":"2002","journal-title":"Pulm Pharmacol Ther"},{"key":"R53-3-20210126","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1164\/rccm.200308-1171OC","article-title":"Effects of inhaled furosemide on exertional dyspnea in chronic obstructive pulmonary disease","volume":"169","author":"Ong","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R54-3-20210126","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0885-3924(01)00367-0","article-title":"Nebulized furosemide as a novel treatment for dyspnea in terminal cancer patients","volume":"23","author":"Shimoyama","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"R55-3-20210126","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S0885-3924(02)00479-7","article-title":"Re: nebulized furosemide for dyspnea in terminal cancer patients","volume":"24","author":"Stone","year":"2002","journal-title":"J Pain Symptom Manage"},{"key":"R56-3-20210126","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1097\/01.PSY.0000097339.75789.81","article-title":"Anxiety and chronic obstructive pulmonary disease: prevalence, impact and, treatment","volume":"65","author":"Brenes","year":"2003","journal-title":"Psychosom Med"},{"key":"R57-3-20210126","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000196202","article-title":"Buspirone effect on breathlessness and exercise performance in patients with chronic obstructive pulmonary disease","volume":"60","author":"Argyropoulou","year":"1993","journal-title":"Respiration"},{"key":"R58-3-20210126","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1164\/ajrccm\/139.4.946","article-title":"Buspirone, an anxiolytic drug that stimulates respiration","volume":"139","author":"Garner","year":"1989","journal-title":"Am Rev Respir Dis"},{"key":"R59-3-20210126","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1164\/ajrccm\/141.6.1527","article-title":"Effects of buspirone on sleep and respiration","volume":"141","author":"Mendelson","year":"1990","journal-title":"Am Rev Respir Dis"},{"key":"R60-3-20210126","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1378\/chest.103.3.800","article-title":"Effects of buspirone on anxiety levels and exercise tolerance in patients with chronic airflow obstruction and mild anxiety","volume":"103","author":"Singh","year":"1993","journal-title":"Chest"},{"key":"R61-3-20210126","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1176\/ajp.152.10.1531a","article-title":"Sertraline for chronic obstructive pulmonary disease and comorbid anxiety and mood disorders","volume":"152","author":"Papp","year":"1995","journal-title":"Am J Psychiatry"},{"key":"R62-3-20210126","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S0033-3182(98)71377-5","article-title":"Sertraline effects on dyspnea in patients with obstructive airways disease","volume":"39","author":"Smoller","year":"1998","journal-title":"Psychosomatics"}],"container-title":["Current Opinion in Supportive & Palliative Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/SPC.0b013e3282ef5e03","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T16:59:57Z","timestamp":1786035597000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01263393-200708000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/spc.0b013e3282ef5e03","relation":{},"ISSN":["1751-4258"],"issn-type":[{"value":"1751-4258","type":"print"}],"subject":[],"published":{"date-parts":[[2007,8]]}}}